English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 54229/89020 (61%)
造访人次 : 10553834      在线人数 : 21
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library & TKU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻

    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://tkuir.lib.tku.edu.tw:8080/dspace/handle/987654321/112696

    题名: New novel α–glucosidase inhibitors produced by microbial conversion
    作者: Nguyen Van Bon, Wang San-Lang
    关键词: α–glucosidase inhibitor;Paenibacillus sp.;Diabetes;Microbial conversion
    日期: 2017-11-21
    上传时间: 2018-02-07 02:10:16 (UTC+8)
    出版者: Elsevier
    摘要: Fermented Nutrient Broth (FNB) was found to be a potential source of antidiabetic drugs in the previous report. Thus, FNB was employed to isolate the active compounds in this study. Novel 5 α-glucosidase inhibitors (aGIs) were isolated from FNB and identified as: (1) Adenine, (2) 3-hydroxyproline, (3) Creatinine, (4) Nicotinic acid, and (5) Niacinamide. Notably, these inhibitors were found as new microbial aGIs, non-sugar-based moiety aGIs. Of these inhibitors, compounds 2 and 4 showed activity against rat α-glucosidase equal to, or stronger than, that
    of acarbose, with the IC50 values of 100, 67, and 115 μg/mL, respectively. These results contributed to enriching the current poor novel microbial aGIs, and also confirmed that FNB shows promising utilization for diabetes and obesity treatments or health foods due to their containing efficient mammalian aGIs.
    關聯: Process Biochemistry, v.65, p.228-232
    DOI: 10.1016/j.procbio.2017.11.016
    显示于类别:[化學學系暨研究所] 期刊論文


    档案 描述 大小格式浏览次数
    New novel α–glucosidase inhibitors produced by microbial conversion.pdf373KbAdobe PDF1检视/开启



    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library & TKU Library IR teams. Copyright ©   - 回馈